Dipexium Pharmaceuticals, Inc.'s CEO was just granted 86,872 options

Natasha Giordano, Dipexium Pharmaceuticals, Inc.'s CEO and a director of the company, just received 86,872 options from the company. The strike price of the options received was $6.72, and these expire on August 11, 2027. Giordano now owns at least 86,872 options on the company.

The above information was disclosed in a filing to the SEC. To see the filing, click here.

To receive a free e-mail notification whenever Dipexium Pharmaceuticals, Inc. makes a similar move, sign up!

Other recent filings from the company include the following:

Dipexium Pharmaceuticals: Plx Pharma Hires Key Commercial Executives In Preparation For Future Launch Of Aspertec - Sept. 19, 2017

Auto Refresh

Feedback